![]()
COURTESY BY: https://www.hindustantimes.com/ With nearly 10 million Covid-19 patients across the globe and over 4.8 coronavirus fatalities, the need for a Covid-19 antidote becomes more urgent by the day. The University of Oxford and AstraZeneca Plc.’s experimental vaccine, ChAdOx1-S, has become the first to enter the final stages of clinical trials against the coronavirus disease. But Oxford and AstraZeneca’s collaborative initiative is not the only one in the race to arrive at a potential Covid-19 vaccine. According to the World Health Organisation’s draft landscape of Covid-19 vaccines, there were 10 candidates in…










